On February 9, 2018, Uber Technologies Inc. agreed to pay $245 million in shares to Waymo, a subsidiary of Alphabet Inc. The settlement announcement came just before the parties were to enter into the fifth day of a jury trial in San Francisco.
Deeth Williams Wallhttps://www.dww.com/articles/uber-settles-trade-secret-dispute-alphabet-subsidiary-waymo-for-245-million
On February 8, 2018, Canada’s Federal Court of Appeal (FCA) dismissed Teva Canada Limited’s consolidated appeals from a Federal Court (FC) decision ordering Teva to pay damages to Janssen Canada and Janssen US for infringement of Canadian Patent No 1,304,080 (the ‘080 Patent) claiming levofloxacin (Janssen’s LEVAQUIN®) (Teva Canada Limited v Janssen Inc,
Deeth Williams Wallhttps://www.dww.com/articles/federal-court-of-appeal-dismisses-teva%E2%80%99s-levofloxacin-patent-damages-appeals
On February 12, 2018, the United States District Court for the East District of New York (the Court) filed its judgment in Cohen v G&M Realty LP. The Court awarded 21 graffiti artists a total of $6.7 million in damages for violation of their rights under the Visual Artists’ Rights Act of 1990 (VARA). The defendants, Gerald Wolkoff and his real estate entities, owned warehouses known as the 5Pointz complex, on which the graffiti artists’ works were displayed.
Deeth Williams Wallhttps://www.dww.com/articles/us-district-court-awards-67-million-usd-damages-for-destruction-of-graffiti-murals
On December 14, 2017, the Canadian Patent Appeal Board (Board) in decision number 1436 regarding an application entitled “Delivery Notice and Method Using the Same” recommended that the application be refused on the basis that claimed invention is directed to non-statutory subject matter, is obvious, and is indefinite.
Deeth Williams Wallhttps://www.dww.com/articles/canadian-patent-appeal-board-rejects-delivery-notice-system-as-unpatentable-subject-matter
On January 25, 2018, in a 2:1 split decision, the US Federal Circuit released its decision in Core Wireless Licensing v LG Electronics Inc, affirming the decision of the United States District Court for the Eastern District of Texas.
Deeth Williams Wallhttps://www.dww.com/articles/graphical-user-interface-menu-structure-found-to-be-patenteligible-subject-matter-us
On January 17, 2018, the Federal Court (FC) dismissed the appeal of Sadhu Singh Hamdard Trust (Trust) from a decision of the Trade-marks Opposition Board (TMOB) refusing the Trust’s application to register the mark AJIT based on its use in association with printed publications and newspapers (Sadhu Singh Hamdard Trust v Navsun Holding
Deeth Williams Wallhttps://www.dww.com/articles/distinctiveness-test-trademark-opposition-not-same-distinctiveness-test-for-passing-off
The Canadian Intellectual Property Office (CIPO) has extended its Patent Prosecution Highway (PPH) pilot agreement with the European Patent Office (EPO) for three years, until January 5, 2021. The PPH program between CIPO and the EPO serves to fast-track patent applications in one country when a patent has been granted in the other.
Deeth Williams Wallhttps://www.dww.com/articles/canadian-intellectual-property-office-and-european-patent-office-extend-patent-prosecution
On January 18, 2018, the Supreme Court of Canada denied Vancouver Career College leave to appeal in Vancouver Community College v Vancouver Career College (Burnaby), 2017 BCCA 41 (previously reported in the
Deeth Williams Wallhttps://www.dww.com/articles/vancouver-career-college-denied-leave-to-appeal-trademark-decision-to-supreme-court-of
Deeth Williams Wall LLP has been listed by Canadian Lawyer Magazine as one of the Top Ten IP Boutiques for 2018. The complete list of Canadian Lawyer Magazine top ranked IP boutiques firms is available online here:
Deeth Williams Wallhttps://www.dww.com/articles/dww-listed-top-ten-ip-boutiques-for-2018-by-canadian-lawyer-magazine
On December 2, 2017, the Government of Canada published Regulations Amending the Patented Medicines Regulations (Proposed Amendments) to include new price regulatory factors that will help enable the Patented Medicine Prices Review Board (PMPRB) to protect Canadian consumers from excessive prices.
Deeth Williams Wallhttps://www.dww.com/articles/canada-publishes-proposed-amendments-to-regulations-on-prices-of-patented-medicines